Human Cytomegalovirus UL7, miR-US5-1, and miR-UL112-3p Inactivation of FOXO3a Protects CD34


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
06 01 2021
Historique:
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 20 8 2021
Statut: epublish

Résumé

Human cytomegalovirus (HCMV) infection of myeloid lineage cells, such as CD34

Identifiants

pubmed: 33408225
pii: 6/1/e00986-20
doi: 10.1128/mSphere.00986-20
pmc: PMC7845589
pii:
doi:

Substances chimiques

Antigens, CD34 0
MicroRNAs 0
Viral Matrix Proteins 0
microRNA-UL112, human cytomegalovirus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI127335
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI021640
Pays : United States

Informations de copyright

Copyright © 2021 Hancock et al.

Références

J Virol. 2007 Oct;81(19):10486-95
pubmed: 17652400
Exp Hematol. 2014 Mar;42(3):218-229.e4
pubmed: 24333663
J Virol. 2020 Jul 30;94(16):
pubmed: 32493823
Annu Rev Virol. 2016 Sep 29;3(1):333-357
pubmed: 27501258
Blood. 1995 Dec 1;86(11):4086-90
pubmed: 7492764
J Immunol. 2006 Nov 1;177(9):6199-206
pubmed: 17056549
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18764-18770
pubmed: 32694203
J Virol. 2016 Jan 06;90(6):3138-47
pubmed: 26739047
Clin Infect Dis. 2002 Apr 15;34(8):1094-7
pubmed: 11914998
Biochem Biophys Res Commun. 2004 Jun 11;318(4):899-903
pubmed: 15147956
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7829-34
pubmed: 11427719
Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17492-17497
pubmed: 31409717
Arch Virol. 2015 Oct;160(10):2483-90
pubmed: 26212361
mBio. 2018 Apr 24;9(2):
pubmed: 29691342
Virology. 2011 Apr 10;412(2):392-400
pubmed: 21333317
Int J Mol Med. 2013 Apr;31(4):959-66
pubmed: 23403649
mBio. 2017 Mar 7;8(2):
pubmed: 28270578
Curr Top Dev Biol. 2018;127:23-47
pubmed: 29433739
J Virol. 2019 Jan 17;93(3):
pubmed: 30404794
Viruses. 2018 Sep 29;10(10):
pubmed: 30274264
J Virol. 2007 Apr;81(7):3109-23
pubmed: 17202209
Cell. 1999 Mar 19;96(6):857-68
pubmed: 10102273
Curr Biol. 2000 Oct 5;10(19):1201-4
pubmed: 11050388
PLoS Pathog. 2011 Dec;7(12):e1002405
pubmed: 22174674
Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69
pubmed: 21236396
J Virol. 2018 Apr 13;92(9):
pubmed: 29467314
J Pathol. 2015 Jan;235(2):288-97
pubmed: 25205255
PLoS One. 2013 Oct 23;8(10):e78355
pubmed: 24194922
Science. 2007 Jun 1;316(5829):1345-8
pubmed: 17540903
Oncogene. 2014 Mar 6;33(10):1258-64
pubmed: 23503461
J Exp Med. 2008 Oct 27;205(11):2551-60
pubmed: 18838543
Methods Mol Biol. 2014;1119:99-112
pubmed: 24639220
Leuk Lymphoma. 2012 Aug;53(8):1586-91
pubmed: 22268450
Proc Natl Acad Sci U S A. 2004 May 25;101(21):7988-93
pubmed: 15148411
J Virol. 2007 Feb;81(3):1511-6
pubmed: 17108038
Virology (Hyderabad). 2017 Aug;1(1):
pubmed: 29082387
Cell Host Microbe. 2015 Jun 10;17(6):838-51
pubmed: 26067606
Virus Genes. 2007 Dec;35(3):577-83
pubmed: 17823862
Viruses. 2012 Sep;4(9):1687-710
pubmed: 23170179
Cancer Lett. 2015 Jan 28;356(2 Pt B):733-42
pubmed: 25449437
J Virol. 2009 Oct;83(20):10684-93
pubmed: 19656885
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14
pubmed: 9482916
Blood. 1992 Jul 1;80(1):170-8
pubmed: 1377049
Biochim Biophys Acta. 2011 Nov;1813(11):1938-45
pubmed: 21708191
mBio. 2014 Oct 28;5(6):e02035
pubmed: 25352622
Nat Cell Biol. 2008 Feb;10(2):138-48
pubmed: 18204439
Noncoding RNA. 2018 Oct 22;4(4):
pubmed: 30360396
Sci Rep. 2017 Apr 20;7(1):937
pubmed: 28428537
J Mol Biochem. 2017;6(1):13-25
pubmed: 28491825
J Immunol. 2002 May 15;168(10):5024-31
pubmed: 11994454
PLoS Pathog. 2019 Nov 14;15(11):e1007854
pubmed: 31725809
J Gen Virol. 1996 Dec;77 ( Pt 12):3099-102
pubmed: 9000102
Immunity. 2015 Jun 16;42(6):1021-32
pubmed: 26084022
Cell Stem Cell. 2007 Aug 16;1(2):140-52
pubmed: 18371346
Immunol Cell Biol. 2011 Oct;89(7):753-66
pubmed: 21670740
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):588-93
pubmed: 22203987

Auteurs

Meaghan H Hancock (MH)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.

Lindsey B Crawford (LB)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.

Wilma Perez (W)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.

Hillary M Struthers (HM)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.

Jennifer Mitchell (J)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA.

Patrizia Caposio (P)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, USA caposiop@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH